|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项 ; _7 N5 |5 v" `) {& F* ]" U0 [
01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.& m. q% h' b8 U9 x( l+ E
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.6 ?7 Y0 W, C/ `' o+ S
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.
. I z5 g8 B$ G$ |04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.
+ g7 T- x4 J/ G5 x" ~( I1 m7 l+ I05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.# `9 g3 q H) l
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy." w8 C" V I# P6 i
07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.
4 Q2 i4 _! k7 V8 ~1 e08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.; ?: i6 w: G) t; N) v# v
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
. W" T5 \" r( e) G+ s. \" K10.Interpretable machine learning for prostate biopsy: Cohort study.3 v$ t: Q) Z8 R( \2 z( ?
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.. L5 h: |& ~& [3 ]7 e
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.( ^4 T0 ?( Z: l& N2 p/ L
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).# D# g7 @9 e6 u5 Q+ u3 R2 F6 u
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).: x5 C1 q7 j4 X7 Z
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
& m4 N# e& e1 a16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
: ~9 b5 g9 H$ Z' m& p17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.' i1 Q+ f' B$ v. k
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.% u, G d1 }2 I$ x- F0 F- [( N
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
( e8 z' N# J8 b1 u+ f20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
; K9 \9 R [2 L" m$ l2 k0 N, Y21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.1 z2 d- o: `& v* e+ f7 I$ S
22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
9 k9 T2 I) \5 c/ ^6 }23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.
; k6 Y* R. |( v" z. d24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.- F# G( b8 f' @1 }
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.
7 n. q1 C) A! N |
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶